Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 04 June 2012 | By Ansis Helmanis,
Brazil's national regulator, Anvisa, will open a public consultation on establishing quality requirements for pharmaceutical excipients used in the manufacture of medicinal products. Excipients include additives such as diluents, flavoring agents and antioxidants.
The Public Consultation No. 31, published 28 May, provides for 60 days of comment beginning June 4 2012. Comments can be submitted using the Ministry of Health's electronic system, FormSUS.
Read more:
Public Consultation No. 31
More Breaking News from RegLink
Tags: Excipients, pharmaceutical, brazil, drug